Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 26. Juni 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8961  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 179217  
   
Robotic Partial Nephrectomy: Different Surgical Approaches for Different Locations.
Cancer Med
Yu L, Zhao X, Duan P, Shu F, Liu Z, Zhang H, Zhang F, Yan Y, Zhang S.
PMID: 42347742 [PubMed - indexed for MEDLINE]


Diagnosis of Prostate Cancer: A Comparative Evaluation of Biological Techniques.
Diseases
Tshoni UA, Mbonane TP, Rathebe PC.
PMID: 42346309 [PubMed]


Mechanisms of Progression and Challenges for Intervention in the Natural History of Early Prostate Cancer: A Narrative Review.
Curr Oncol
Sandhu K, Pacey S, Brewer DS, Gnanapragasam VJ.
PMID: 42346270 [PubMed - indexed for MEDLINE]


Automated PROMISE V2 Scoring from PSMA PET/CT Reports Using Large Language Models: A Comparative Evaluation of Prompt Design and Model Performance.
Curr Oncol
Speicher T, Demirkol IE, Blickle A, Bastian MB, Maus S, Schaefer-Schuler A, Bartholomä M, Burgard C, Ezziddin S, Rosar F.
PMID: 42346249 [PubMed - indexed for MEDLINE]


Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter Analysis.
Curr Oncol
Meagher MF, Birouty N, Musso G, Patil D, Saito K, Yasuda Y, Puri D, Baker B, Yuen K, Roberts JL, Ahdoot A, Baker O, Dabbas M, Cortes J, Fujii Y, Master V, Liss M, Derweesh IH.
PMID: 42346227 [PubMed - indexed for MEDLINE]


Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network.
Curr Oncol
Di Napoli M, Coppola E, D'Aniello C, Scagliarini S, Buonerba C, Muto A, Formisano L, Sabbatino F, Bosso D, Rossetti S, Lobianco L, Tambaro R, Di Costanzo F, Rescigno P, Pisano C, Cecere SC, Passarelli A, Ventriglia J, Calvanese G, Lamia MR, Perri E, Contieri R, Franzese D, Simeoni MA, Giorgio CM, Feroce F, Stilo S, Pacifico G, Canciello G, Pignata S.
PMID: 42346225 [PubMed - indexed for MEDLINE]


Metastatic Tumour Burden as Prognostic Factor in Nivolumab-Treated Metastatic Renal Cell Carcinoma: An Exploratory Study.
Curr Oncol
Uccello M, Gee AL, Bennett JA, Hazell HL, Ruiz-Echarri Rueda M, Beresford MJ.
PMID: 42346220 [PubMed - indexed for MEDLINE]


Pembrolizumab-Associated Polyserositis with Eosinophilic Pleural Effusion During Adjuvant Therapy for Clear Cell Renal Cell Carcinoma: A Case Report and Targeted Review.
Curr Oncol
Portu M, Sanz-Beltran J, Duarte Borges MA, Navarro J, Arias A, Alvarez P, Fernández-Rebollo A, Reyes C, Flores J, Anguera G, Maroto P.
PMID: 42346214 [PubMed - indexed for MEDLINE]


Cancer Detection and Surveillance Pathways with Abbreviated MRI in the Prostate, Pancreas, and Liver: A Risk-Stratified Narrative Review.
Curr Oncol
Brown H, Clarke SE.
PMID: 42346206 [PubMed - indexed for MEDLINE]


Incidence and Short- to Intermediate-Term Oncological Outcomes of Pathological T0 Prostate Cancer After Robot-Assisted Radical Prostatectomy: A Multicenter, Retrospective Cohort Study in Japan (MSUG94 Group).
Curr Oncol
Tomioka-Inagawa R, Tomioka M, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T, Sakaguchi K, Makiyama K, Inoue T, Kitamura H, Saito K, Koga F, Urakami S, Koie T.
PMID: 42346203 [PubMed - indexed for MEDLINE]


Diagnostic Value of Immunohistochemical Markers GATA3, Cyclin D1, KRT20, and GLUT1 in Renal Neoplasms.
Int J Surg Pathol
Barakzai MA, Arain SA, Afsar NA, Alsouss YO, Al-Hussain T.
PMID: 42345527 [PubMed - as supplied by publisher]


PET-MR Examination in Diagnosing Bone Metastases in Prostate Cancer.
Cancer Manag Res
Su X, Li K, Wang J, Jiang Z, Shan L.
PMID: 42344703 [PubMed]


A pathological morphology parameter-based prognostic nomogram for high-risk prostate cancer patients treated with neoadjuvant therapy followed by radical prostatectomy: a retrospective study.
World J Surg Oncol
Liang H, Fan J, Xu K, Song H, Gan C, Wang G, Kang Q, Liu J, He D, Fan J, Wu K.
PMID: 42343460 [PubMed - as supplied by publisher]


Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials.
Eur Urol Oncol
Scilipoti P, , Thibault C, Doma, Necchi A, Montorsi F, Briganti A, Moschini M, Masson-Lecomte A, Kamat AM, Xylinas E, Pradere B, Shariat S, Trinh QD, Birtle A, Grande E, Bellmunt J, Loriot Y, Rouprêt M, Seisen T.
PMID: 42342498 [PubMed - as supplied by publisher]


Oncological Outcomes of Non-Muscle Invasive Bladder Cancer in Patients Aged ≤45: A Retrospective Matched Cohort Study.
J Urol
St-Laurent MP, Din S, Moryousef J, Lajkosz K, Kwong JCC, Chan A, Kim J, Taborek A, Chadee A, Sadri I, Reznik G, Tin C, Fleshner NE, Kulkarni GS, Black PC, Kassouf W, Zlotta AR.
PMID: 42341207 [PubMed - as supplied by publisher]


Robot-Assisted versus Laparoscopic Radical Nephrectomy for High-Complexity Renal Tumors: A Multidisciplinary Systematic Review and Meta-Analysis.
Clin Ter
Elnemr M, Sharif MH, Mahmoud HM, Abdalgaleel MA, Elshazly S, Mhanna T, Rezk T, Allam KA, Albachaan M, Ghoneimy OM, Aboelgheit G, Mohammed SA, Alaghbar K, Kayed AAA, Oda MA.
PMID: 42340793 [PubMed - indexed for MEDLINE]


Optimal MRI sequence for predicting extraprostatic extension in prostate cancer: comparison of LCC and MaxRADD measurements.
Abdom Radiol (NY)
Ilanjian G, Matthey J, Porões F, Valerio M, Richemond A, Dagher J, Rakauskas A, Dromain C, Jreige M, Vietti-Violi N.
PMID: 42340465 [PubMed - as supplied by publisher]


Correction: Assessment of radiotherapy effect and toxicity using tissue-associated DNA methylation markers in cell-free DNA: a study on prostate cancer.
Radiat Environ Biophys
Bahtiyar N, Mermut O, Firtina S, Ozaydin A, Suleymanova A, Isikgil B, Onaran .
PMID: 42340384 [PubMed - as supplied by publisher]


A Practical Guide to PSMA PET Radiopharmaceuticals for Prostate Cancer Imaging, From the AJR Special Series on Molecular Imaging.
AJR Am J Roentgenol
Peacock JG, Franquet-Elia E, Harris AL, Weeks JG, Kuo PH.
PMID: 42340235 [PubMed - as supplied by publisher]


Magnetic resonance imaging radiomic phenotypes stratify response and define immune states in very high-risk, nonmuscle-invasive bladder cancer treated with tislelizumab plus nanoparticle albumin-bound paclitaxel.
Cancer
Huang S, Jia K, Liang S, Ma B, Chen H, Zhang Z, Kang N, Wu Z, Lin Y, Li P, Xue Z, Chen H, Zhao Y, Guo J, Li C, Chai W, Cui J, Xu G, Qie Y, Shen C, Hu H.
PMID: 42339693 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 179217    Seite 1 von 8961  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1